Superficial mycoses.
Twenty-five years ago many of the topical remedies for superficial mycoses were irritating, toxic, or allergenic. Total x-ray depilation of the scalp was the accepted mode of therapy for tinea capitis. The introduction of topical nystatin for candidiasis and tolnaftate for dermatophytosis were major advances, but tinea capitis, onychomycosis, and chronic tinea pedis still presented problems. Soon after its introduction in 1958, griseofulvin became the definitive form of therapy for all types of dermatophytosis and played a major role in abolishing large-scale epidemics of tinea capitis in some countries. Recently, haloprogin and the imidazole derivatives, miconazole and clotrimazole, which are topically active against dermatophytes and Candida albicans, have become available. Selective indicator media for isolating dermatophytes are useful diagnostic tools, but quicker methods of diagnosis which require little interpretation are still lacking. Epidemiologic studies in Vietnam again revealed the effects of climate and occlusion on the prevalence, incidence, and severity of superficial mycoses and led to renewed interest in host susceptibility, environment, and prevention of infections.
D000287:Administration, Topical; D000328:Adult; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D003883:Arthrodermataceae; D002177:Candidiasis / Q000188:drug therapy; D003881:Dermatomycoses / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D005260:Female; D006118:Griseofulvin / Q000627:therapeutic use; D006204:Hair Removal; D006801:Humans; D008297:Male; D009761:Nystatin / Q000008:administration & dosage / Q000627:therapeutic use
D000935:Antifungal Agents; D009761:Nystatin; D006118:Griseofulvin